The TLR4-MyD88 Signaling Axis Regulates Lung Monocyte Differentiation Pathways in Response to Streptococcus pneumoniae-Reference-Cited by-同舟云学术

The TLR4-MyD88 Signaling Axis Regulates Lung Monocyte Differentiation Pathways in Response to Streptococcus pneumoniae

Published:2020-09-16 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Sánchez-Tarjuelo Rodrigo,Cortegano Isabel,Manosalva Juliana,Rodríguez Mercedes,Ruíz Carolina,Alía Mario,Prado María Carmen,Cano Eva M.,Ferrándiz María José,de la Campa Adela G.,Gaspar María Luisa,de Andrés Belén

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference70 articles.

1. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease.;Kadioglu;Nat Rev Microbiol.,2008

2. The worldwide impact of the seven-valent pneumococcal conjugate vaccine.;Fitzwater;Pediatr Infect Dis J.,2012

3. Estimates of the severity of coronavirus disease 2019: a model-based analysis.;Verity;Lancet Infect Dis.,2020

4. Epidemiology of pneumococcal diseases in Spain after the introduction of pneumococcal conjugate vaccines.;Marimon;Enferm Infecc Microbiol Clin.,2020

5. Drug-resistant Streptococcus pneumoniae.;Campbell;Clin Infect Dis.,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential applications of dual haptoglobin expression in the reclassification and treatment of hepatocellular carcinoma;Translational Research;2024-10

2. A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome;European Respiratory Review;2024-07

3. Recombinant human proteoglycan 4 lowers inflammation and atherosclerosis susceptibility in female low‐density lipoprotein receptor knockout mice;The Journal of Physiology;2024-04-12

4. NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins;Nature Communications;2024-03-07

5. Targeting Toll-like receptor 4 (TLR4) and the NLRP3 inflammasome: Novel and emerging therapeutic targets for hyperuricaemia nephropathy;Biomolecules and Biomedicine;2023-12-01